Community Healthcare Trust Inc — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Community Healthcare Trust Inc filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $121.20M | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $115.79M | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $112.85M | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | $97.68M | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $90.58M | Feb 13, 2024 |
| FY2022 | Dec 31, 2020 | $75.68M | Feb 14, 2023 |
| FY2019 | Dec 31, 2019 | $16.83M | Feb 25, 2020 |
| FY2019 | Sep 30, 2019 | $16.26M | Feb 25, 2020 |
| FY2019 | Jun 30, 2019 | $14.32M | Feb 25, 2020 |
| FY2019 | Mar 31, 2019 | $13.44M | Feb 25, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.10M | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | ($3.18M) | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $7.71M | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | $22.02M | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $22.49M | Feb 13, 2024 |
| FY2022 | Dec 31, 2020 | $19.08M | Feb 14, 2023 |
| FY2019 | Dec 31, 2019 | $2.21M | Feb 25, 2020 |
| FY2019 | Sep 30, 2019 | $2.65M | Feb 25, 2020 |
| FY2019 | Jun 30, 2019 | $2.07M | Feb 25, 2020 |
| FY2019 | Mar 31, 2019 | $1.45M | Feb 25, 2020 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $56.43M | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $58.88M | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $61.38M | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | $60.28M | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $56.35M | Feb 13, 2024 |
| FY2022 | Dec 31, 2020 | $48.37M | Feb 14, 2023 |
| FY2021 | Dec 31, 2019 | $32.36M | Feb 15, 2022 |
| FY2020 | Dec 31, 2018 | $24.44M | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | $22.13M | Feb 25, 2020 |
| FY2018 | Dec 31, 2016 | $14.93M | Feb 26, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $990.76M | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $992.56M | Feb 17, 2026 |
| FY2024 | Dec 31, 2023 | $945.41M | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | $876.43M | Feb 13, 2024 |
| FY2022 | Dec 31, 2021 | $754.23M | Feb 14, 2023 |
| FY2021 | Dec 31, 2020 | $668.40M | Feb 15, 2022 |
| FY2020 | Dec 31, 2019 | $562.53M | Feb 16, 2021 |
| FY2019 | Dec 31, 2018 | $426.57M | Feb 25, 2020 |
| FY2018 | Dec 31, 2017 | $385.77M | Feb 26, 2019 |
| FY2015 | Dec 31, 2015 | $142.80M | Feb 26, 2016 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $561.37M | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $516.60M | Feb 17, 2026 |
| FY2024 | Dec 31, 2023 | $432.16M | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | $379.61M | Feb 13, 2024 |
| FY2022 | Dec 31, 2021 | $292.12M | Feb 14, 2023 |
| FY2021 | Dec 31, 2020 | $238.49M | Feb 15, 2022 |
| FY2020 | Dec 31, 2019 | $209.12M | Feb 16, 2021 |
| FY2019 | Dec 31, 2018 | $154.91M | Feb 25, 2020 |
| FY2018 | Dec 31, 2017 | $102.39M | Feb 26, 2019 |
| FY2015 | Dec 31, 2015 | $20.53M | Feb 26, 2016 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $429.39M | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $475.97M | Feb 17, 2026 |
| FY2024 | Dec 31, 2023 | $513.26M | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | $496.81M | Feb 13, 2024 |
| FY2022 | Dec 31, 2021 | $462.11M | Feb 14, 2023 |
| FY2022 | Dec 31, 2020 | $429.92M | Feb 14, 2023 |
| FY2022 | Dec 31, 2019 | $353.41M | Feb 14, 2023 |
| FY2021 | Dec 31, 2018 | $271.66M | Feb 15, 2022 |
| FY2020 | Dec 31, 2017 | $283.37M | Feb 16, 2021 |
| FY2019 | Dec 31, 2016 | $194.01M | Feb 25, 2020 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.34M | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $4.38M | Feb 17, 2026 |
| FY2024 | Dec 31, 2023 | $3.49M | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | $11.23M | Feb 13, 2024 |
| FY2022 | Dec 31, 2021 | $2.35M | Feb 14, 2023 |
| FY2021 | Dec 31, 2020 | $2.48M | Feb 15, 2022 |
| FY2020 | Dec 31, 2019 | $1.73M | Feb 16, 2021 |
| FY2019 | Dec 31, 2018 | $2.01M | Feb 25, 2020 |
| FY2018 | Dec 31, 2017 | $2.13M | Feb 26, 2019 |
| FY2015 | Dec 31, 2015 | $2.02M | Feb 26, 2016 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $532.20M | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $485.96M | Feb 17, 2026 |
| FY2024 | Dec 31, 2023 | $403.26M | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | $353.00M | Feb 13, 2024 |
| FY2022 | Dec 31, 2021 | $265.63M | Feb 14, 2023 |
| FY2021 | Dec 31, 2020 | $212.37M | Feb 15, 2022 |
| FY2020 | Dec 31, 2019 | $194.24M | Feb 16, 2021 |
| FY2019 | Dec 31, 2018 | $147.77M | Feb 25, 2020 |
| FY2018 | Dec 31, 2017 | $93.35M | Feb 26, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 13, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Feb 14, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Feb 25, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Feb 25, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Feb 25, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Feb 25, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Feb 13, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Feb 14, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Feb 25, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Feb 25, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Feb 25, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Feb 25, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 28.47M | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | 28.24M | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | 27.61M | Feb 17, 2026 |
| FY2025 | Dec 31, 2022 | 25.90M | Feb 17, 2026 |
| FY2024 | Dec 31, 2021 | 24.98M | Feb 18, 2025 |
| FY2023 | Dec 31, 2020 | 23.89M | Feb 13, 2024 |
| FY2022 | Dec 31, 2019 | 21.41M | Feb 14, 2023 |
| FY2021 | Dec 31, 2018 | 18.64M | Feb 15, 2022 |
| FY2020 | Dec 31, 2017 | 18.09M | Feb 16, 2021 |
| FY2019 | Dec 31, 2016 | 12.99M | Feb 25, 2020 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $53.67M | Feb 17, 2026 |
| FY2025 | Dec 31, 2024 | $51.70M | Feb 17, 2026 |
| FY2025 | Dec 31, 2023 | $48.06M | Feb 17, 2026 |
| FY2024 | Dec 31, 2022 | $44.49M | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $42.41M | Feb 13, 2024 |
| FY2022 | Dec 31, 2020 | $38.03M | Feb 14, 2023 |
| FY2021 | Dec 31, 2019 | $31.95M | Feb 15, 2022 |
| FY2020 | Dec 31, 2018 | $29.38M | Feb 16, 2021 |
| FY2019 | Dec 31, 2017 | $24.43M | Feb 25, 2020 |
| FY2018 | Dec 31, 2016 | $17.78M | Feb 26, 2019 |